Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
287 studies found for:    "Arbovirus Infections"
Show Display Options
Rank Status Study
1 Completed Pilot Survey of Dengue Fever in Solomon Islands
Condition: Arbovirus Infections
2 Completed Field Evaluation of Plant-based Mosquito Control
Conditions: Malaria;   Arbovirus Infections
Intervention: Device: anti-mosquito plant use
3 Recruiting Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)
Conditions: Zika Virus;   Dengue Virus;   Chikungunya Virus Infections
4 Recruiting Cohort of Patients Infected by an Arbovirus
Conditions: Fever;   Dengue;   Chikungunya;   Zika Virus
Interventions: Other: biological sample collection;   Other: quality of life questionnaire EuroQol®;   Other: Health Assessment Questionnaire - MDHAQ and RAPID3
5 Enrolling by invitation A Zika Virus DNA Vaccine in Healthy Adults and Adolescents
Conditions: Zika Virus;   Zika Virus Infection;   Virus Diseases;   Flavivirus Infections;   Flaviviral Diseases;   Flaviviridae Infections;   RNA Virus Infections
Interventions: Biological: VRC-ZKADNA090-00-VP;   Other: VRC-PBSPLA043-00-VP
6 Completed Safety and Immunogenicity Study of Rift Valley Fever Vaccine
Condition: Rift Valley Fever
Intervention: Biological: RVF Vaccine
7 Recruiting Phase I, Randomized, Double-blinded, Placebo-Controlled Dose De-escalation Study to Evaluate Safety and Immunogenicity of Alum Adjuvanted Zika Virus Purified Inactivated Vaccine (ZPIV) in Adults in a Flavivirus Endemic Area
Condition: Zika Virus Infection
Interventions: Other: Placebo;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
8 Recruiting A Phase 1, First-in-human, Double-blinded, Randomized, Placebo-controlled Trial of a Zika Virus Purified Inactivated Vaccine (ZPIV) With Alum Adjuvant in Healthy Flavivirus-naive and Flavivirus-Primed Subjects.
Condition: Zika Virus Infection
Interventions: Biological: IXIARO;   Biological: YF Vax 17D Strain;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
9 Recruiting ZIKA Vaccine in Naive Subjects
Condition: Zika Virus Infection
Interventions: Drug: Saline;   Biological: Zika Virus Purified Inactivated Vaccine (ZPIV)
10 Recruiting Zika Virus Infection's Neonatal and Pediatric Consequences in French Department of America
Condition: Zika Virus Infection on Fetus and Child During the Pregnancy
Interventions: Other: fundus examination;   Other: Head ultrasound
11 Recruiting Persistence of Zika Virus in Semen After Acute Infection
Conditions: Zika Virus;   Zika Virus Disease;   Virus Shedding;   Transmission
12 Enrolling by invitation Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
Condition: Rift Valley Fever
Intervention: Biological: Inactivated, Dried (TSI-GSD 200), RVF Vaccine
13 Not yet recruiting Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil
Condition: Zika Virus
Intervention: Diagnostic Test: RT-PCR
14 Recruiting Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability
Condition: Zika Virus
Interventions: Biological: MV-ZIKA;   Other: Placebo
15 Recruiting Understanding Excretion and Infectivity of Zika Virus in Semen During and After Infection
Condition: Zika Virus
Intervention: Other: Semen analysis and semen PCR for Zika virus
16 Completed Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers
Conditions: Dengue;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus;   Biological: DTaP IPV//Hib vaccine;   Biological: Placebo;   Biological: Measles, mumps, and rubella vaccine;   Biological: Pneumococcal vaccine
17 Completed
Has Results
Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America
Conditions: Dengue;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotype 1 , 2, 3 , and 4 virus;   Biological: NaCl 0.9%;   Biological: Tetanus toxoid, reduced diphtheria toxoid, acellular pertussis vaccine adsorbed;   Biological: Meningococcal A+C vaccine
18 Completed A Study of Balapiravir in Patients With Dengue Virus Infection
Condition: Dengue
Interventions: Drug: balapiravir [RO4588161];   Drug: placebo
19 Completed Safety of and Immune Response to Two Different Dengue Virus Vaccines in Individuals Previously Immunized Against Dengue Virus
Condition: Dengue Hemorrhagic Fever
Interventions: Biological: rDEN1delta30;   Biological: rDEN2/4delta30(ME);   Biological: Placebo to rDEN1delta30 or rDEN2/4delta30(ME)
20 Recruiting Zika in Infants and Pregnancy (ZIP)
Condition: Zika Virus Disease (Disorder)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.